Augmenting Ureagenesis in Patients with Partial Carbamyl Phosphate Synthetase 1 Deficiency with N-carbamyl-l-glutamate - 22/07/14
Abstract |
Identical studies using stable isotopes were performed before and after a 3-day trial of oral N-carbamyl-l-glutamate (NCG) in 5 subjects with late-onset carbamyl phosphate synthetase deficiency. NCG augmented ureagenesis and decreased plasma ammonia in 4 of 5 subjects. There was marked improvement in nitrogen metabolism with long-term NCG administration in 1 subject.
Le texte complet de cet article est disponible en PDF.Keyword : CPS1, NAGS, NCG
Plan
| Supported by the National Institutes of Health (R01HD058567, R01DK47870, R01DK64913, U54RR019453, P01HD26979, NS054900, and RR024134) and the O’Malley Family Foundation. The Urea Cycle Disorders Consortium (U54RR019453) is a part of the Rare Disease Clinical Research Network, supported through a collaboration between the Office of Rare Diseases Research, National Center for Advancing Translational Sciences, and Eunice Kennedy Shriver National Institute of Child Health and Human Development. The authors declare no conflicts of interest. |
Vol 165 - N° 2
P. 401 - août 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
